The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Size Expansion Is Predicted For The Pharmaceutical Sterility Testing Market Between 2026 And 2030?
The pharmaceutical sterility testing market size has seen substantial growth in recent years. This market is projected to expand from $1.68 billion in 2025 to $2.07 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 23.7%. The historical expansion can be ascribed to the increasing need for sterile pharmaceutical products, the limited availability of advanced testing laboratories, the growing pharmaceutical production and biologics pipelines, the reliance on conventional sterility testing methods, and a rising awareness of quality control standards.
The pharmaceutical sterility testing market is poised for substantial expansion in the upcoming years, with its valuation projected to reach $4.91 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 24.1%. This anticipated growth during the forecast period is primarily driven by advancements in automated sterility testing technologies, the increasing expansion of outsourcing testing services, the integration of AI and digital monitoring tools, the rising adoption of rapid microbiological methods, and growing regulatory mandates for biologics and gene therapies. Key developments anticipated for this period include a rising demand for in-house and outsourced sterility testing services, the growing adoption of bioburden and endotoxin testing in pharmaceutical manufacturing, increasing use of advanced instruments, kits, and reagents for sterility analysis, the expansion of testing services for biologics, vaccines, gene, and cell therapies, and an enhanced focus on regulatory compliance and quality assurance in sterility testing.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2826&type=smp
What Drivers Are Influencing The Pharmaceutical Sterility Testing Market?
The pharmaceutical sterility testing market is projected to expand driven by the increasing sales of biologics. Biologics, or biological products, are medicines derived from living organisms, including various items such as vaccines, blood and blood components, allergenics, somatic cells, gene therapies, tissues, and recombinant therapeutic proteins. Pharmaceutical sterility testing offers essential quality control to confirm that these biologics are free from microbial contamination before being administered to patients. For instance, in October 2024, the Generics and Biosimilars Initiative, a Belgium-based organization that delivers high-quality scientific information on generic and biosimilar medicines, noted that in 2023, two complex drugs recorded substantial sales in addition to the nine leading biologics. Novo Nordisk’s Ozempic (semaglutide) and Eli Lilly’s Trulicity (dulaglutide), both prescribed for type 2 diabetes, generated sales of US$14 billion and US$7.2 billion, respectively. Therefore, the growth in biologics sales is a key driver for the pharmaceutical sterility testing market.
Which Market Segments Are Examined In The Pharmaceutical Sterility Testing Market Study?
The pharmaceutical sterility testing market covered in this report is segmented –
1) By Sample: Sterile Drugs, Medical Devices, Biologics and Therapeutics
2) By Product Type: Instruments, Kits and Reagents, Services
3) By Service Type: In- house, Outsourcing
4) By Test Type: Sterility Testing, Bioburden Testing, Bacterial Endotoxin Testing
5) By End- User: Compounding Pharmacies, Medical Devices Companies, Pharmaceutical Companies
Subsegments:
1) By Sterile Drugs: Injectable Drugs, Infusion Solutions, Ophthalmic Solutions
2) By Medical Devices: Surgical Instruments, Implants, Catheters
3) By Biologics And Therapeutics: Vaccines, Gene Therapies, Cell Therapies
Which Trends Are Influencing The Pharmaceutical Sterility Testing Market?
Key players within the pharmaceutical sterility testing sector are concentrating on devising innovative solutions, such as Advanced biological indicators, to expedite sterility verification, boost testing accuracy, and improve general manufacturing safety. Advanced biological indicators are specialized instruments that contain highly resilient microorganisms, used to swiftly and precisely confirm the efficacy of sterilization processes in pharmaceutical production. As an illustration, in September 2025, Nelson Labs, a contract testing laboratory based in the US, introduced the RapidCert Biological Indicator (BI) sterility testing platform. This innovative system considerably reduces the time necessary to ascertain sterility, enhancing efficiency in pharmaceutical manufacturing and enabling quicker product release while upholding strict quality criteria.
Who Are The Primary Competitors In The Pharmaceutical Sterility Testing Market?
Major companies operating in the pharmaceutical sterility testing market are Pacific Biolabs Inc., STERIS Corporation, Boston Analytical Inc., Gibraltar Laboratories Inc., Sartorius AG, Solvias AG, SGS S.A., Toxikon Inc., Pace Analytical Services LLC, Charles River Laboratories International Inc., Nelson Laboratories Inc., Rapid Micro Biosystems Inc., bioMérieux Inc., Merck KGaA, WuXi AppTec, Sotera Health LLC, Dynalabs LLC, Infinity Laboratories, Eurofins Scientific SE, Avomeen Analytical Services, Microbac Laboratories Inc., Analytical Lab Group LLC, North American Science Associates Inc., Medical Device Testing Services Inc., Microtest Laboratories Inc., BioScreen Testing Services Inc., Microchem Laboratory Inc., Bactolac Pharmaceutical Inc., Micro Quality Labs Inc., BioPharma Services Inc., Microbiology Research Associates, BioScience Laboratories Inc.
Read the full pharmaceutical sterility testing market report here:
Which Regions Are Expected To Experience Rapid Expansion In The Pharmaceutical Sterility Testing Market?
North America was the largest region in the pharmaceutical sterility testing market in 2025. The Middle East is expected to be the fastest-growing region in the global pharmaceutical sterility testing market share during the forecast period. The regions covered in the pharmaceutical sterility testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Pharmaceutical Sterility Testing Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=2826&type=smp
Browse Through More Reports Similar to the Global Pharmaceutical Sterility Testing Market 2026, By The Business Research Company
Pharmaceutical Drugs Market Report 2026
https://www.thebusinessresearchcompany.com/report/pharmaceutical-drugs-global-market-report
Pharmaceutical Excipient Market Report 2026
https://www.thebusinessresearchcompany.com/report/pharmaceutical-excipient-global-market-report
Pharmaceutical Packaging Equipment Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model